Discovery of novel resorcinol biphenyl ether-based macrocyclic small molecules as PD-1/PD-L1 inhibitors with favorable pharmacokinetics for cancer immunotherapy-Reference-Cited by-同舟云学术

Discovery of novel resorcinol biphenyl ether-based macrocyclic small molecules as PD-1/PD-L1 inhibitors with favorable pharmacokinetics for cancer immunotherapy

Published:2023-10 Issue: Volume:139 Page:106740
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Yang Zichao^ORCID,Liu Ziqing,Xu Chenglong,Xu Jianwei,Liu Ting,He Haiqi,Li Ling,Ren Yichang,Chen Jianjun^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference47 articles.

1. Small molecule-based immunomodulators for cancer therapy;Wu;Acta Pharm. Sin. B,2022

2. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?;Feng;Cancer communications (London, England),2019

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

4. Recent advances in the clinical development of immune checkpoint blockade therapy;Ghahremanloo;Cell. Oncol.,2019

5. S.C. Wei, C.R. Duffy, J.P. Allison, Fundamental Mechanisms of Immune Checkpoint Blockade Therapy, Cancer discovery 8 (2018) 1069-1086.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 4-phenyl-1H-indazole derivatives as novel small-molecule inhibitors targeting the PD-1/PD-L1 interaction;Bioorganic Chemistry;2024-06

2. Discovery of Novel Small-Molecule-Based Potential PD-L1/EGFR Dual Inhibitors with High Druggability for Glioblastoma Immunotherapy;Journal of Medicinal Chemistry;2024-05-13

3. Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction;Chemical Communications;2024